ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Shire gears up to battle Allergan's Linzess with new constipation drug Motegrity
December 19, 2018Takeda is set to gulp up Shire, whether disgruntled investors like the deal or not. But for those in the latter camp, the biotech’s latest approval may make it easier to swallow. -
Bausch Health inks $200M ‘stalking horse’ deal for bankrupt Trulance maker Synergy
December 14, 2018Could a still-recovering company buying a distressed one create a better business? Bausch Health apparently thinks so when it comes to Synergy Pharma, as it's agreed to pay $200 million for the now-bankrupt maker of Trulance.
Pharma Sources Insight January 2025
